The Biopharmaceuticals Contract Manufacturing Global Market Report 2023, provides comprehensive information on the biopharmaceuticals contract manufacturing market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Biopharmaceuticals Contract Manufacturing Market’s Growth:
https://www.thebusinessresearchcompany.com/report/biopharmaceuticals-contract-manufacturing-global-market-report
As per The Business Research Company’s Biopharmaceuticals Contract Manufacturing Global Market Report 2023, the market size is expected to grow from $16.54 billion in 2022 to $18.31 billion in 2023 at a compound annual growth rate (CAGR) of 10.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global biopharmaceuticals contract manufacturing market size is expected to reach $26.88 billion in 2027 at a CAGR of 10%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=10181&type=smp
Product innovations are a key trend gaining popularity in the biopharmaceuticals contract manufacturing market. Major companies operating in the biopharmaceutical contract manufacturing market are developing innovative products to sustain their position in the market. For instance, in February 2023, Thermo Fisher Scientific, a US-based biotechnology research company, and Elektrofi, a US-based biotechnology company specializing in drug formulation and delivery innovations, entered into a strategic contract manufacturing agreement to support the commercial production of Elektrofi’s ground-breaking ultra-high concentration subcutaneous products. Elektrofi’s proprietary microparticle technology enables small-volume injections of biologics such as monoclonal antibodies, therapeutic proteins, and other large-molecule medications important for human health. Elektrofi’s platform technology allows patients to self-inject medicines at home rather than in a hospital setting, overcoming the difficulties of administering biologic-based medications.
The biopharmaceuticals contract manufacturing market is segmented:
1) By Product: Biologics, Monoclonal Antibodies (MABs), Recombinant Proteins, Vaccines, Antisense, RNAi, And Molecular Therapy, Biosimilars
2) By Source: Mammalian, Non-mammalian
3) By Service: Process Development, Fill And Finish Operations, Analytical And QC studies, Packaging
4) By Application: Clinical, Commercial
North America was the largest region in the biopharmaceuticals contract manufacturing market in 2022.
The table of contents in TBRC’s biopharmaceuticals contract manufacturing market report includes:
1. Executive Summary
2. Biopharmaceuticals Contract Manufacturing Market Characteristics
3. Biopharmaceuticals Contract Manufacturing Market Trends And Strategies
4. Biopharmaceuticals Contract Manufacturing Market – Macro Economic Scenario
5. Biopharmaceuticals Contract Manufacturing Market Size And Growth
………………………..
26. Africa Biopharmaceuticals Contract Manufacturing Market
27. Biopharmaceuticals Contract Manufacturing Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Biopharmaceuticals Contract Manufacturing Market
29. Biopharmaceuticals Contract Manufacturing Market Future Outlook and Potential Analysis
30. Appendix
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
